Meyer Antje, Salewsky Bastian, Buchmann Nikolaus, Steinhagen-Thiessen Elisabeth, Demuth Ilja
Research Group on Geriatrics, Charitx00E9; - Universitx00E4;tsmedizin Berlin, Berlin, Germany.
Gerontology. 2016;62(3):330-6. doi: 10.1159/000430950. Epub 2016 Jan 29.
The length of the chromosome ends, telomeres, is widely accepted as a biomarker of aging. However, the dynamic of the relationship between telomere length and hematopoietic parameters in the normal aging process, which is of particular interest with respect to age-related anemia, is not well understood.
We have analyzed the relationship between relative leukocyte telomere length (rLTL) and several hematological parameters in the older group of the Berlin Aging Study II (BASE-II) participants. This paper also compares rLTL between both BASE-II age groups (22-37 and 60-83 years).
Genomic DNA was extracted from peripheral blood leukocytes of BASE-II participants and used to determine rLTL by a quantitative PCR protocol. Standard methods were used to determine blood parameters, and the WHO criteria were used to identify anemic participants.
Telomere length data were available for 444 younger participants (28.4 ± 3.1 years old; 52% women) and 1,460 older participants (68.2 ± 3.7 years old; 49.4% women). rLTL was significantly shorter in BASE-II participants of the older group (p = 3.7 × 10-12) and in women (p = 4.2 × 10-31). rLTL of older men exhibited a statistically significant, positive partial correlation with mean corpuscular hemoglobin (MCH; p = 0.012) and MCH concentration (p = 0.002). While these correlations were only observed in men, the rLTL of older women was negatively correlated with the number of thrombocytes (p = 0.015) in the same type of analysis. Among all older participants, 6% met the criteria to be categorized as 'anemic'; however, there was no association between anemia and rLTL.
In the present study, we have detected isolated correlations between rLTL and hematological parameters; however, in all cases, rLTL explained only a small part of the variation of the analyzed parameters. In disagreement with some other studies showing similar data, we interpret the association between rLTL and some of the hematological parameters studied here to be at most marginal. This applies also to the role of rLTL in anemia, at least in the age group investigated here. Since BASE-II is yet another large cohort in which women have on average shorter telomeres than men, this finding will be addressed in the discussion with respect to the ongoing debate on gender differences in telomere length.
染色体末端的端粒长度被广泛认为是衰老的生物标志物。然而,在正常衰老过程中端粒长度与造血参数之间关系的动态变化,尤其是与年龄相关性贫血相关的方面,目前尚不清楚。
我们分析了柏林衰老研究II(BASE-II)老年组参与者的相对白细胞端粒长度(rLTL)与多个血液学参数之间的关系。本文还比较了BASE-II两个年龄组(22 - 37岁和60 - 83岁)之间的rLTL。
从BASE-II参与者的外周血白细胞中提取基因组DNA,并通过定量PCR方案用于测定rLTL。使用标准方法测定血液参数,并采用世界卫生组织标准识别贫血参与者。
有444名年轻参与者(28.4±3.1岁;52%为女性)和1460名老年参与者(68.2±3.7岁;49.4%为女性)的端粒长度数据。老年组的BASE-II参与者(p = 3.7×10 - 12)和女性(p = 4.2×10 - 31)的rLTL显著更短。老年男性的rLTL与平均红细胞血红蛋白含量(MCH;p = 0.012)和MCH浓度(p = 0.002)呈统计学显著的正偏相关。虽然这些相关性仅在男性中观察到,但在相同类型的分析中,老年女性的rLTL与血小板数量呈负相关(p = 0.015)。在所有老年参与者中,6%符合“贫血”分类标准;然而,贫血与rLTL之间没有关联。
在本研究中,我们检测到rLTL与血液学参数之间存在单独的相关性;然而,在所有情况下,rLTL仅解释了所分析参数变异的一小部分。与其他显示类似数据的一些研究不同,我们认为rLTL与这里研究的一些血液学参数之间的关联至多是边缘性的。这也适用于rLTL在贫血中的作用,至少在所研究的年龄组中如此。由于BASE-II是另一个大型队列,其中女性的端粒平均比男性短,这一发现将在关于端粒长度性别差异的持续辩论的讨论中进行探讨。